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This review details the core activity in cellular agriculture conducted in 
the UK at the end of 2019, based upon a literature review by, and 
community contacts of the authors. Cellular agriculture is an 
emergent field in which agricultural products—most typically animal-
derived agricultural products—are produced through processes 
operating at the cellular level, as opposed to (typically farm-based) 
processes operating at the whole organism level. Figurehead example 
technologies include meat, leather and milk products manufactured 
from a cellular level. Cellular agriculture can be divided into two 
forms: ‘tissue-engineering based cellular agriculture’ and 
‘fermentation-based cellular agriculture’. Products under development 
in this category are typically valued for their environmental, ethical, 
and sometimes health and safety advantages over the animal-derived 
versions. 
 
There are university laboratories actively pursuing research on meat 
products through cellular agriculture at the universities of Bath, 
Newcastle, Aberystwyth, and Aston University in Birmingham. A 
cellular agriculture approach to producing leather is being pursued at 
the University of Manchester, and work seeking to produce a palm oil 
substitute is being conducted at the University of Bath. The UK cellular 
agriculture companies working in the meat space are Higher Steaks, 
Cellular Agriculture Ltd, CellulaRevolution, Multus Media and 
Biomimetic Solutions. UK private investors include CPT Capital, 
Agronomics Ltd, Atomico, Backed VCs, and Breakoff Capital. The UK 
also has a strong portfolio of social science research into diverse 
aspects of cellular agriculture, with at least ten separate projects 
being pursued over the previous decade. Three analyses of the 
environmental impact of potential cellular agriculture systems have 
been conducted in the UK. The first dedicated third-sector group in 
this sector in the UK is Cultivate (who produced this report) followed 
by Cellular Agriculture UK. International groups New Harvest and the 
Good Food Institute also have a UK presence.
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            Amendments from Version 1
This new version of the paper has been updated in response to 
the reviewers’ comments in the following ways:
An extended introductory paragraph expanding upon the paper’s 
aim and key audiences.
A clarification that ‘tissue engineering-based cellular agriculture’ 
includes structured and unstructured products.
Note that the entire replacement of animal agriculture is only a 
possibility.
Additional overview information on some technical challenges 
facing cellular agriculture.
Additional notes on the anticipated benefits of fermentation-based 
palm oil.
A reordering of the text about the historical context of cellular 
agriculture.
Additional paragraph about Dr Mark Kotter’s work at the 
University of Cambridge.
Additional content in the social science section providing extra 
detail on the content of the work discussed and detailing their 
funding sources.
Additional notes on the funding of Cultivate.
Additional reflection upon the role of the University of Bath in UK 
cellular agriculture.
Additional note on the limited formal relationships between the 





Cellular agriculture is an emergent field in which agricultural 
products—most typically animal-derived agricultural products— 
are produced through processes operating at the cellular 
level, as opposed to (typically farm-based) processes operating 
at the whole-organism level. This review details the cellular 
agriculture landscape in the UK at the time of publishing, 
providing an overview of key actors in the sector from a range 
of backgrounds, including university and corporate laboratory 
research, private investors, social science, Life Cycle Analyses, 
and policy work. The aim of the review is to collate information 
on the UK context in a form that is not currently available in the 
public domain. It provides a brief overview of the key groups and 
individuals involved, and identifies each by the sector in which 
they operate. The goal is to provide a brief and accessible review 
that, where possible, signposts readers to further sources that 
can be pursued for additional information. As such it is not 
intended as a detailed overview of the technical aspects of 
the work discussed. Instead, the review provides a basis for 
subsequent discussion both within and beyond the UK about 
activity in the country. We anticipate it will have value for 
policy-makers, academics, NGOs, and other actors interested 
in learning about and engaging with cellular agriculture in the 
UK, and will form a building block upon which subsequent 
discussion can be conducted.
The term cellular agriculture was first coined in 2015 by Isha 
Datar, Executive Director of US-based 3rd sector group New 
Harvest. Potential future products bracketed under the label 
cellular agriculture include meat produced though tissue 
engineering (variously known as cultured meat, clean meat, 
cell-based meat and cultivated meat (referred to herein as 
CM)), and animal-derived products such as milk, leather and 
egg white produced through recombinant DNA fermentation 
techniques (Datar et al., 2016; Stephens et al., 2018). As 
these examples suggest, cellular agriculture is typically 
divided into two types, based on the technology form used. 
The first has been called ‘tissue engineering-based cellular 
agriculture’ (Stephens et al., 2018) and involves taking cells 
from live (or recently deceased) animals and culturing these 
cells so as to control their cell proliferation and differentiation to 
direct the formation of increasing quantities of a desired cell 
type (e.g. muscle and fat for meat, skin for leather). We use 
this term to capture work on both structured and unstructured 
products (e.g. mincemeats and full tissue meats). The second 
type of cellular agriculture has been termed ‘fermentation-based 
cellular agriculture’ (ibid) and involves genetically modifying 
typically bacteria, yeast or algae by adding recombinant 
DNA so that when they are fermented in sugars they pro-
duce organic molecules that can subsequently be processed to 
biofabricate familiar products such as milk and leather.
While the term cellular agriculture is less than five years old, 
the technologies it describes have a longer history. In terms of 
tissue engineering-based cellular agriculture, the first work 
to increase the mass of in vitro muscle under laboratory 
conditions happened around the millennium (Benjaminson 
et al., 2002; Catts & Zurr, 2002), with further work in the 
following decade (Puy et al., 2010; Wilschut et al., 2008). In 
terms of fermentation-based cellular agriculture, some suggest 
the historical lineage can be drawn as far back as industrially- 
produced rennet used in manufacturing cheese, which has 
used recombinant DNA techniques since the 1990s to replace 
enzymes taken from ruminant mammals, typically after their 
slaughter. However, manufacturers using this technique have not 
adopted the term cellular agriculture and do not feature within 
the emergent cellular agriculture community, so we do not include 
rennet in our review. Similarly, some products that are naturally 
produced in plants can be made using fermentation, such as 
flavour molecules and oils like vanilin, but these have not 
generally be classed as cellular agriculture to date. It could be 
argued that they fall under the same umbrella if their goal is the 
same (i.e. sustainable production), as is the case of the palm oil 
substitute discussed later.
The call for cellular agriculture is generally motivated by a set 
of related concerns about the impacts of animal agriculture 
as it exists today and the challenges of the increased global 
population in the coming decades. Cellular agriculture can 
be said to be directed at addressing UN Sustainable Develop-
ment Goal Two (Zero Hunger) and Goal Twelve (Responsible 
Consumption and Production). While the exact form the 
potential contribution of cellular agriculture may take varies 
from case to case, the recurrent themes are a concern with the 
environmental impact of animal agriculture (in terms of land 
use, greenhouse gas emissions, impact on biodiversity etc., see 
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Bhat et al., 2015; Mattick, 2018), as well as animal ethics con-
cerns about livestock living conditions and slaughter (Milburn, 
2018; Schaefer & Savulescu, 2014), and the impact on human 
health of animal agriculture through issues such as animal-borne 
disease and antibiotic use (Arshad et al., 2017; Specht et al., 
2018). The view is that cellular agriculture will allow the con-
tinued production of familiar animal products while using either 
fewer or no animals in the process. The aim is that this would 
result in either reducing (or perhaps entirely replacing) animal 
agriculture, or that it would slow the increase in global use of 
animals in agriculture to meet global rising demand for animal 
products driven by population and wealth increases. This 
given, while there is optimism within the community, a number 
of substantial technical hurdles remain. This includes produc-
ing culture media at a lower cost; developing cell lines that 
have the capacity for indefinite propagation and have a high 
culture-efficiency to maximise product yield; developing reli-
able automation and bioreactor systems to enable scale-up that is 
net-zero carbon; and reproducing the taste, texture and 
nutritional profile of familiar peat products (Stephens et al., 2018; 
Thorrez & Vandenburgh, 2019).
In this review we suggest the common-use definition of 
cellular agriculture could be expanded to also include the 
cellular production of agricultural goods that are not sourced 
from animals, here reflecting upon the example of fermentation- 
based palm oil production (an active area of research in the 
UK). Intuitively this makes sense, as this fermentation-based 
work is producing agricultural products at the cellular level. 
This work also ties to environmental and animal welfare 
concerns, specifically around deforestation and its impact upon 
greenhouse gases and biodiversity, that are also seen expressed 
in different ways elsewhere within the cellular agriculture 
community. However, at this stage, we raise this as just a pos-
sibility, and do not seek to assert a new definition upon the 
field.
Global context
The leading nations in cellular agriculture today arguably are the 
US, the Netherlands, and Israel, although work is conducted in 
numerous other countries, including the UK. In terms of CM, the 
first larger scale project was conducted in the Netherlands from 
2005 onwards. One member of this initial consortia, Prof Mark 
Post of Maastricht University, went on to secure funding from 
Google co-founder Sergey Brin to produce the world’s first 
laboratory-grown hamburger, which was cooked and tasted at 
a press conference in London in 2013 (O’Riordan et al., 2017; 
Post, 2014). The interest this generated fed into a change of 
culture within the international CM community, as the first 
10–15 years of largely university-based research shifted towards 
the emergence of a start-up culture (Stephens et al., 2019). While 
University research has continued, the focus has shifted to the 
swiftly increasing number of early stage companies in the area, 
seeking and securing venture capital seed funding for their 
work. Among the highest profile in the US are Memphis Meats, 
who were the first CM company to secure series A funding of 
$17m, and the vegan-mayonnaise and liquid egg company Just 
(formally Hampton Creek) who have also established a CM 
R&D initiative. Others include Mission Barns, Wild Type, and 
Bluefin tuna-focused Finless Foods. Outside of the US, the 
Netherlands has remained a key site with Post following his burger 
press conference with the establishment of a start-up, Mosa Meat, 
which in 2018 announced a funding round of €7.5m. A second 
company, Meatable, also runs out of Leiden. Israel also has a 
strong base, with companies including Future Meat Tech-
nologies and Aleph Farms, who recently completed a funding 
round of $11.65m. Other examples include Japan-based 
Integriculture, Singapore-based Shiok Meats, and Canada-
based Appleton Meats. As private entities, it is not always 
clear exactly what proprietary technology each company is 
developing, or how advanced their technology is.
In terms of fermentation-based cellular agriculture, the inter-
national context is dominated by US companies, particularly 
those based in the San Francisco Bay area. Key examples include 
Geltor, who produce gelatin, Clara Foods, who produce egg 
white, and both Perfect Day and New Culture, who produce 
animal-free dairy products. Outside of California, the most 
prominent company is Modern Meadow, who ferment collagen 
to use in manufacturing leather-like products. Modern Meadow 
were initially the first company to work on CM, but later 
focused exclusively on leather. Beyond the US, the main example 
would be Japan-based Spiber, who make spider silk. Further 
information on the global context can be found in State of the 
Industry Reports for CM and plant-based meats, eggs and dairy 
from the Good Food Institute.
Histories of cellular agriculture often include two key UK- 
related components, both related to CM. The earliest is a 
regularly repeated quotation from Winston Churchill in a 1931 
article titled ‘Fifty Years Hence’, in which he states “[w]e shall 
escape the absurdity of growing a whole chicken in order to eat 
the breast or wing, by growing these parts separately under 
a suitable medium” (Churchill, 1931). Typically, people from 
the community follow the quotation by noting it is taking longer 
than Churchill predicted, but the trajectory was correct. The 
second UK-related historical milestone is the 2013 London 
press conference in which Post and his team at Maastricht 
University unveiled the world’s first cultured burger, which 
had been grown in his laboratory in the Netherlands and 
transported to the UK just before. The burger was a proof of 
concept as opposed to a product launch, as it was reported to 
have cost around $300,000. It was tasted by two independent 
food journalists from Austria and the US, after being cooked 
by chef Richard McGeown, patron of Couch’s Great House 
Restaurant in Cornwall, UK (O’Riordan et al., 2017; Post, 2014).
Review methodology
This review is rooted in a ten-year social science project 
conducted by N.S. This project has involved over 50 interviews 
with experts internationally in CM, as well as attendance at key 
meetings and media analysis of reporting on the subject. N.S. 
and M.E. are part of a group that co-founded an organisation 
named ‘Cultivate’ in 2016 to act as a multi-voiced forum 
for discussing issues around cellular agriculture in the UK. 
Cultivate organises an annual event to bring together the UK 
cellular agriculture community. During its November 2018 
event a draft document produced by N.S. on UK activity in this 
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area was circulated and commented upon by those present. 
After this, N.S. followed up the suggestions made in that 
discussion and conducted further desk-based research and 
direct contact with groups involved to develop the work reported 
here. This exercise was addressed again during Cultivate event in 
November 2019 to up-date and finalise the review.
As noted above, cellular agriculture is an emerging field, and 
much of the leading research has been conducted within private 
companies that do not typically publish their research. As such, 
this review includes fewer references to peer-reviewed sources 
than would be the case in a typical review article. This is by 
necessity, as there are only a limited number of peer-reviewed 
papers available on this novel area of research. Subsequently this 
review combines references to peer-reviewed research with grey 
literature found in reports, institutional websites, and media 
reporting.
We note that we ourselves are among the most active in this 
field in the UK, and as such we review our own work as part 
of this text. We also note that cellular agriculture can some-
times seem a fast moving field, with new entrants appearing 
frequently. Often in the commercial sphere such entities operate 
in what is termed ‘stealth mode’, to indicate a low profile. As 
such, it is possible our account may miss some UK activity, 
and can only claim to capture the context as we know it to be at 
the time of publication.
In the following sections we review key aspects of UK cellular 
agriculture activity, focusing upon different clusters of activity 
in turn.
University laboratory research
The most active university in the UK is the University of Bath. 
Dr Marianne Ellis and Dr Chris Chuck are the bioprocessing 
strand lead and director, respectively, in the Centre for Integrated 
Bioprocessing Research (CIBR). The Ellis group focuses on 
tissue engineering-based cellular agriculture; the Chuck group 
focuses on fermentation-based cellular agriculture, specifically 
production of a palm oil substitute from yeast. Ellis began her 
research career in regenerative medicine and has applied her 
bioprocess design techniques to the expansion of muscle 
cells for CM. Given her experience with in vitro liver models 
(Luetchford et al., 2018; Storm et al., 2016) and her early-
career work on scaffold development for mesenchymal stem cell 
expansion (Morgan et al., 2007), she has positioned herself to 
develop platform technologies for a wide range of tissue engi-
neered cellular agriculture products, specifically based around 
scalable bioreactor design (Allan et al., 2019). She has a research 
group, with funding from New Harvest amongst others, devel-
oping bioreactors and scaffolds for CM, and gives Chemical 
Engineering undergraduate students the opportunity to carry 
out major project work in this space, having now supervised 
over 30 Masters of Engineering student projects on the topic of 
cultured meat bioprocess design. The work combines tissue 
engineering with established biotechnology process design 
with the addition of novel approaches to scaling up tissue 
engineering cultures. Focus is on bioreactor configuration; 
given the early stage of this work, much effort is going into 
understanding the metabolic stoichiometry, i.e. how much raw 
material is consumed by the cells to produce a given amount of 
protein as well as the waste products. This is intimately linked to 
efficient scale up due to it being the basis for media recipes 
and amounts required, which is likely to be affected by cell type 
and culture conditions.
Aberystwyth University has recently started working on cellular 
agriculture via a PhD student co-funded by M.E.’s start-up, 
Cellular Agriculture Ltd, the Institute of Biology, Environment 
and Rural Sciences (IBERS) at Aberystwyth University and 
the Pedigree Welsh Pig Society. The project is examining cell 
sourcing and harvest for cultured pig meat. To our knowledge 
this is the first and only study in the world exploring the 
properties of primary porcine cells to find the most efficient 
for CM production. This type of research is commonplace in 
traditional meat production, albeit for the whole animal, and it 
follows that there will be particular breeds whose cells are more 
conducive to the bioreactor culture environment than others, 
thus leading to a more efficient production process, like the 
broiler chicken, and even a customer-preferred source likened to 
prime cuts of meat like Aberdeen Angus beef.
Also, in 2019, US-led third sector group the Good Food Insti-
tute provided $210,088 funding to Petra Hanga, lecturer in 
Biological Engineering at Aston University, to work on bio-
processing and scale-up. Her focus is upon microtissues com-
posed of fat and muscle in a scalable bioreactor platform. Working 
with bovine mesenchymal stem cells, the project aims to optimise 
protocols for increased cell production.
From 2018 until late 2019, US-based third sector group New 
Harvest have also been funding Dr Ricardo M. Gouveia at 
Newcastle University to investigate how substrate curvature 
effects the migration, proliferation and self-organisation of 
cells within a matrix, and how controlling this could support 
targeted bio-fabrication of tissues that reproduce the texture of 
meat. This work is based within the lab of Prof Che J. Connon, 
which is also connected to the start-up CellulaREvolution 
discussed in the next section.
At the University of Cambridge, academic neurosurgeon 
Dr Mark Kotter has developed work on human induced pluripo-
tency stem cells to produce neurons and skeletal myocytes 
for biomedical purposes (Pawlowski et al., 2017). Kotter’s 
new technology – named OPTi-OX – has been licensed to the 
Netherlands-based company Meatable, who are using it to develop 
a CM system. Kotter co-founded Meatable, along with Krijn de 
Nood and Daan Luining, in 2018, with its aims including produc-
ing a pork prototype. 
Returning to the University of Bath, and moving away from CM, 
Chuck has been working on the scale up of oleaginous 
yeasts grown on waste resources for the production 
of a palm oil substitute (Parsons et al., 2018; Whiffin et al.,  
2016). Funded by a £3.9m grant from the EPSRC 
and Innovate UK, this MP² Project is a collaboration 
between the University of Bath, University of York, Croda, 
and AB Agri. They seek to create a sustainable biorefinery 
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that uses food waste biomass that has been broken down with a 
one-step and additive-free microwave technology to hydrolyse 
the materials into fermentable sugars. Then, using oleaginous 
yeast as a platform mechanism, the MP² Project group seek 
to develop a pilot-industrial scale bioreactor to produce larger 
quantities of single cells oils that can operate as a palm oil sub-
stitute for some purposes. Their current research involves optimis-
ing the yeast strain being used, and assessing the mechanics and 
economics of a scale-up system. The long-term goal is to pro-
duce a palm oil substitute—the world’s most widely used oil 
crop—with a system involving less deforestation and the 
associated habitat destruction.
Finally, moving away from food but remaining with cellular 
agriculture, in 2019 an Engineering and Physical Sciences 
Research Council-funded PhD project commenced at 
the University of Manchester. Supervised by Dr Celina 
Jones, Dr Olga Tsigkou and Dr Lucy Bosworth, the project 
aims to pair a synthetic scaffold with 3D cell culture 
techniques to produce a new uniformed textile-cell 
construct, or ‘leather’. The vision is to enable traditional fibre-
scaffolds to be transformed into unique fabrics using textile 
processes. These biodegradable fabrics would then be cultured 
with fibroblasts, which should secrete extracellular matrix pro-
teins (including collagen and elastin), and eventually be modified 
to be comparable to the dermis layer of the skin. This ‘artificial’ 
skin would then be subjected to traditional tanning processes, 
minus a number of previously essential steps, in an attempt to 
create a mechanically stable,  uniform leather material.
Companies
The most visible CM company in the UK is Higher Steaks, 
founded by Benjamina Bollag (CEO), Dr Stephanie Wallis (CSO), 
and Prof David Hay (Scientific Director) in 2017. Higher Steaks 
is a ‘full stack’ company, meaning its focus is upon producing 
a consumer ready CM product, as well as working on all the 
intermediary steps in a vertically integrated form. They are 
developing a technology that could use skin biopsies or blood 
samples from pigs to which an induced pluripotency technique 
is applied to create cells that could produce any type of tissue 
including muscle and fat for use in pork products. Pork has 
been chosen as the initial focus as porcine biology is close to 
human biology, allowing biomedical insights to be more eas-
ily translated, and because of Higher Steaks’ concern that pigs 
in the meat industry have a higher exposure to antibiotics than 
cattle. However, they also expect their technology to be appli-
cable to other species in the future. Like many full stack CM 
start-ups, they are also working to develop methods for reduc-
ing the cost of the media in which their cells are grown, as media 
is the highest costing input to the process. On this, they have 
already established culturing protocols that work sufficiently 
well without fetal bovine serum (an animal-derived blood 
product), but are continuing research efforts in this area. In 
mid-2019, the team was made up of Bollag and Wallis and a stem 
cell scientist, while Hay contributed in parallel to his role as the 
chair of the Tissue Engineering department at MRC Centre for 
Regenerative Medicine at the University of Edinburgh. They also 
have a team of advisors. Higher Steaks raised a pre-seed round 
and are currently preparing for their seed round and anticipate 
expanding once further capital is secured.
While Higher Steaks have been more visible, the first CM com-
pany to be established in the UK was Cellular Agriculture Ltd, 
founded in 2016 by Illtud Dunsford and Ellis. The company 
is in some regards distinct internationally: co-founder Dunsford’s 
background is in farming as the owner of a successful meat 
production and processing business set on the family farm of 
300 years (Charcutier Ltd), giving the company an unusual 
grounding in traditional meat production. Cellular Agriculture 
Ltd has not adopted a ‘full stack’ business model and does not 
seek to produce meat themselves. Instead they are commercial-
ising the bioprocess with focus on the bioreactor technology, 
developed in the Ellis laboratory at the University of Bath, to 
enable the industry to manufacture their products on a commer-
cial scale. The company is leveraging its university contacts, 
and co-funds two PhD students alongside US-based 3rd sector 
group New Harvest and the University of Bath for bioreactor 
design, and Aberystwyth University for cell sourcing and 
harvesting. It has also developed its own proof of concept 
bioreactor via InnovateUK funding. In mid-2019 they were 
preparing their seed round.
There have been, and continue to be, other companies with 
UK links active in the field. CellulaREvolution Ltd are a new 
spin out company from Newcastle University co-founded by Leo 
Groenewegen CEO, Dr Martina Miotto CSO and Prof. Che 
Connon CTO. The team work with peptides for multiple purposes. 
This includes developing methods for continuous bioprocess-
ing in which cells automatically self-detach from their growing 
surface to allow other cells to subsequently grow in the same 
space. This substantially increases production yields, all within a 
serum-free environment whilst reducing media volume and foot-
print (Miotto et al., 2017). Their research was originally devel-
oped for medical uses, particularly the cornea, but they are now 
exploring applications in both biomedicine and CM 
(CellulaREvolution, 2018). In November 2019, CellulaREvo-
lution announced a £380,000 investment via the North East 
Angel R&D programme, managed by Northstar Ventures.
Also recently established, Multus Media are seeking to produce 
animal-free, sustainable and cheap media for the CM industry. 
Their approach is to use genetically engineered yeast to produce 
mammalian cell growth factors. Based out of Imperial College 
Advanced Hackspace (ICAH) in London, the project is led by 
Kevin Pan with a team of 13 other scientists.
Another start-up, Biomimetic Solutions, is also exploring 
developing enabling technologies with applications in both 
CM and biomedicine. Starting in Brazil, the company moved to 
London in 2018 and participated in the RebelBio accelerator 
programme. Currently Biomimetic Solutions retains links to 
both Brazil and the UK. They have patented a scaffold called 
Nano3D that is edible and pH neutral that could provide a 
framework for muscle cells to grow into as CM is produced. The 
scaffold has been trialled by US CM company Finless Foods 
(Benz, 2018).
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Private investors
The most active private funder of cellular agriculture work in 
the UK is CPT Capital, a dedicated investor in the alternative 
protein sector. It is run through the family office of Jeremy 
Coller, a successful financial executive. They have invested in 
both plant-based proteins (including famous names like Beyond 
Meat and Impossible Foods) as well as a string of cellular 
agriculture companies, including Geltor (gelatine), Perfect 
Day and New  Culture (both dairy products), Modern Meadow 
and Vitro Labs Inc (both leather), and Blue Nalu, Aleph Farms, 
Memphis Meats, and Mosa Meat (all CM). While these are 
largely US-based companies, CPT Capital are now “looking to 
expand the geographic representation” of their portfolio. They 
look for pre-seed to Series B stage companies with a view to 
long-term support.
The second most active investor in the sector that we are 
currently aware of is Agronomics Limited, who focus specifi-
cally on nascent modern foods that target environmental benefits. 
Their listed investments include BlueNalu, New Ages 
Meats, Shiok Meats and Meatable. Other single company 
investments from the UK include Atomico’s investment 
in Memphis Meats, Backed VC’s investment in the Dutch com-
pany Meatable, and Breakoff Capital’s investment in Finless 
Foods. Other UK-related investors include Richard Branson, 
who famously invested in Memphis Meats Series A round, and, 
as reported above, biotech incubator RebelBio (backed by glo-
bal venture capital firm SOSV), who supported Biomimetic 
Solutions.
Social science
The UK has a broad range of social science analyses of cellular 
agriculture. The earliest was an economic forecast produced 
by eXmoor pharma concepts (2008). This work was funded by 
the Dutch-led In Vitro Meat Consortium project, and predicted 
CM could be produced for €3300–3500 per tonne, compared to 
about €1800 per tonne for chicken meat. 
At this time, sociologist Dr Neil Stephens began an extended 
project, still continuing today, tracking the long-term devel-
opment of CM and the community that supports it. His early 
work identified the ontological ambiguity over what CM 
actually is—as meat, or as meat alternative, or even not as 
food at all—and has subsequently documented the technical 
and cultural moves that have sought to define its status and 
politics (O’Riordan et al., 2017; Stephens, 2010; Stephens, 2013; 
Stephens & Ruivenkamp 2016; Stephens et al., 2018; Stephens 
et al., 2019). Stephens’ work has received funding from the 
Economic and Social Research Council, the Wellcome Trust, 
and via a larger FP7 project (titled EPINET). It has stressed the 
symbolic work conducted by those within the cultured meat 
community to assert frames of reference that position the politics 
of cultured meat in specific ways. 
Continuing the interdisciplinary theme, lawyer Dr Ludivine 
Petetin (2014), then of the University of Hull, published work 
identifying key questions about the politics and policy 
landscape of CM, before arguing EU regulation needed strength-
ening in response to CM, in order to strike a balance between 
ensuring risk management is accomplished effectively, while 
avoiding stifling innovation. 
In more work funded by the Wellcome Trust, bioethicists 
Dr Owen Schaefer and Prof Julian Savulescu (2014), then of 
the University of Oxford, argued CM is permissible and worth 
promoting. They found potential moral objections – disrespect 
towards animals, reduction of happy animal numbers, and risks 
of cannibalism – are insufficiently serious to undermine the 
potential positives offered by the technology. 
2014 also saw the first UK academic meeting dedicated 
largely to CM. Titled ‘The Ethics of In-Vitro Flesh and 
Enhanced  Animals’ and hosted by Dr Jan Deckers in the small 
Northumberland Town of Rothbury, the two-day event featured 
a range of social science papers addressing the issue. Along 
with Stephens and Schaefer, another attendee was geographer 
Dr Alexandra Sexton, now of the University of Oxford and a 
co-founder of Cultivate. Funded initially by the ESRC, and 
then as part of the broader Wellcome Trust funded Livestock, 
Environment and People (LEAP) Project, Sexton has analysed 
the political framing of CM in relation to similar narratives 
found among emerging plant-based meat companies. Her work 
documents the narratives through which CM is presented as an 
edible, and transformative, technology, and how political 
notions of what constitutes ‘good’ food and ‘good consumers’ 
are articulated through this (Sexton, 2016; Sexton, 2018; Sexton 
et al., 2019). 
Over the next couple of years, a number of reports on 
public perceptions of CM were published. The first was by an 
international group including staff at the University of Bath 
(Marcu et al., 2015). Funded as part of a European Union FP7 
project, this work looked at perceptions in the UK, Portugal 
and Belgium, and found participants’ accounts often connected 
CM to existing reference points to make sense of it, be that 
familiar metaphors, science fiction, or their existing opinions on 
the politics of food technology and commercialisation. A second 
study, funded by and conducted with the Tyndall Centre for 
Climate Change Research at the University of Manchester 
(O’Keefe et al., 2016), looked at focus group responses to a range 
of food practices intended to address climate change, including 
CM. It found consumers did not strongly link food choices 
to climate change, but were more likely to embrace changes 
that fit more closely to their existing competencies and 
practices. More recently, Christopher Bryant, working with the 
Bath group and funded by the UK Economic and Social Research 
Funding Council, has published a further set of survey-based 
consumer analyses (Bryant & Barnett, 2018). His findings 
include the observation that consumer positivity towards CM 
increases when it is called ‘clean meat’ as opposed to ‘lab grown 
meat’ (Bryant & Barnett, 2019), and, in work funded by the 
Animal Advocacy Research Fund, that India and China have 
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higher levels of acceptance for cultured meat than the USA, 
and higher familiarity predicted higher acceptance (Bryant 
et al., 2019). Finally on public perceptions, Professor Frank 
Vriesekoop of Harper Adams University has worked with a 
team of international colleagues on consumers perspectives 
in the UK, Spain, Brazil and the Dominican Republic 
(Gómez-Luciano et al., 2019). They found readiness to con-
sume alternative proteins was greater in higher income countries, 
and that consumers found plant-based proteins more attractive 
than CM. 
Recently, Dr Josh Milburn, of the University of Sheffield, has 
also written supportively on the ethics of cultured meat and milk. 
On CM, Milburn argues appropriate safeguards can be put in 
place to prevent harm to animals from which cells are extracted, 
and hierarchies between humans and animals can be over-
come by using humans as the cell source for CM (Milburn, 
2016). Milburn then argues cultured milk has key differences 
ethically to CM in that milk is unambiguously food, and never 
part of an animal’s body. Cultured milk, Milburn argues, 
should be supported while ensuring it does not stand to legiti-
mate the current milk industry, while again noting that cultured 
human milk would undermine any concerns about reasserting 
human-animal hierarchies (Milburn, 2018).
Finally, John Miller, also of the University of Sheffield and 
another attendee of the 2014 Rothbury event, is writing on the 
literary history of CM. He identifies science fiction narratives 
concerning CM as early as 1881, and analyses in detail a 
depiction from the 1952 novel ‘The Space Merchants’ (Pohl & 
Kornbluth, 1984) that on one hand gestures towards a politics 
that values traditional meat production over CM, but on the 
other engages with the problems of capitalism that frame meats 
produced in any form (Miller, 2019).
Environmental life cycle analyses
Life cycle analyses (LCA) assess the environmental impact 
across the lifecycle of a particular product or output. Such work 
has inherent difficulties in the context of cellular agriculture as 
the products being modelled are still early in their research and 
development process, and have not yet entered scale-up processes. 
As such LCAs on the topic involve making multiple assump-
tions, or the use of the closest real-world example in the absence 
of empirical material on actual cellular agriculture processes. 
However, potential environmental benefits are key motivators 
for many cellular agriculture products, so a number of attempts 
have been made to quantify what this benefit would be. Three of 
these have been produced in the UK. The earliest of these was the 
first LCA of CM produced anywhere in the world, by Dr Hannah 
Tuomisto, then of Oxford University, working with Dr Joost 
Teixeira De Mattos of the University of Amsterdam. As well 
as the first, this LCA has to date remained the most optimistic, 
suggesting that compared to conventionally produced European 
meat, a CM system could result in 7–45% lower energy use, 
78–96% less greenhouse gas emissions, 99% lower land use, 
and 82–96% lower water use (Tuomisto & de Mattos, 2011). 
Four years later, Dr Mark Steer of the University of the West of 
England conducted an LCA of milk produced through cellular 
agriculture, based on the work of San Francisco start-up Muufri 
(now Perfect Day). The modelling here found Muufri’s milk could 
use 35% of the energy, 16% of the greenhouse gases, 1% of the 
land and 2% of the water compared to the conventional dairy 
industry (Steer, 2015). Finally, more recently in 2019, another 
Oxford University group published an LCA of CM com-
paring a wider set of potential production and use contexts 
than previous work, and looked across multiple timeframes, 
up until 1,000 years in the future. The study found that, while 
in many instances CM is climatically superior to conventional 
livestock production, some scenarios may exist in which this 
is not the case (Lynch & Pierrehumbert, 2019).
3rd sector groups, charities and think tanks
There are two dedicated UK-based third sector groups in the 
UK, as well as UK representation of international (generally 
US-based) groups and a level of interest among UK third sec-
tor groups with a broader remit. The first dedicated UK third 
sector group was ‘Cultivate’, founded in 2016 by an interdisci-
plinary and cross-sector team of five (that include the authorship 
team of this review). It describes itself as “a multi-voiced forum 
intended to support informed dialogue about the emergent field 
of cellular agriculture from UK perspectives”. It formed after 
the group who went on to become its founders were invited to 
a number of discussions at 10 Downing Street about UK policy 
in this area, during which they produced a review of UK activity 
and a set of policy recommendations, one of which was to estab-
lish the networking group that became Cultivate. A significantly 
reedited version of their report went on to be published as 
Stephens et al., (2018). Cultivate have hosted an annual 
meeting since 2016 and produce written outputs on the topic. The 
organisation operates without external funding and functions with 
low costs. Events are supported by attendee entrance fees and 
founder contributions.
A second dedicated UK third sector group was established in 
2018. ‘Cellular Agriculture UK’ seeks to “provide a clear, central 
hub and contact point for those who have independently 
developed interest in the space” and to “reach out to potential 
interested parties and support their engagement in the space” 
(Cellular Agriculture, 2018) and held their first activities in 
early 2019. Beyond these UK-based groups, three US based 
groups also have UK representation. The Cellular Agriculture 
Society have UK-based volunteers. The Good Food Institute 
now has a representative in the UK, having recently employed 
its first UK-based staff member, Richard Parr, as their Managing 
Director (EU); as noted previously, they have funded Hanga’s 
research at Aston University. Another leading US-based third 
sector group—New Harvest—fund PhD research at the Ellis lab 
at the University of Bath and Gouveia’s work at Newcastle 
University, as well as earlier work at King’s College London and 
the University of Oxford.
Additionally, a number of UK groups with broader focus have 
produced reports about CM, including the Adam Smith Institute 
(Hollywood & Pirie, 2018), the Food Ethics Council (2015) 
and the Nuffield Council on Bioethics (2019). Among the most 
detailed is a report by Chatham House (Froggatt & Wellesley, 
2019) that specifically articulates considerations for the EU. In 
particular, they raise issues relating to how regulation and 
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labelling decisions made by policy-makers could frame future 
direction and pace of growth.
Conclusion
Cellular agriculture, both as a term and as a field of activity, 
remains relatively new. Those developing the technologies 
associate it with a range of significant benefits, but the 
technology remains early-stage in many cases, and the capacity 
of these technologies to deliver these benefits remains unknown 
and subject to the social context of their introduction. The 
technologies have garnered support over the last five years from 
a set of technology investors, often with links to Silicon Valley 
finances or modes of working. UK activity, in this context, is 
increasing but remains smaller than that found in countries such 
as the US, Israel and the Netherlands.
The longest-standing UK work has been university-based. The 
University of Bath is a leading institution among these, in part 
as it was an early-mover, and due to its existing track-record in 
bioprocessing, but also partly due to chance in that Bath has 
three separate groups (one of which is based in the Depart-
ment of Psychology, two based in the Department of Chemical 
Engineering) that have independently chosen to work in this 
area. More recently the number of companies has been growing. 
Unlike many of the American, Israeli and Dutch companies, 
all but one UK company have adopted a business-to-business 
model, seeking to supply components necessary for CM 
production to other CM companies. The exception is Higher 
Steaks, who have adopted the full-stack model of seeking to 
produce marketable CM products. We also note that all of 
the UK companies are focused upon CM, with none of them 
addressing the broader set of cellular agriculture products. 
These companies are either seeking, or have gained, initial seed 
funding, but have attracted less finance than the leading 
companies globally. Also notable is that the UK-based investors 
have most frequently directed their finance outside of the UK, 
primarily to the US, and have invested less domestically.
We have demonstrated that the UK has a long history of lively 
work on the social and policy aspects of cellular agriculture, 
covering key but diverse topics including the production of 
meaning, consumer responses, economics and regulatory 
analysis. This is not, we suggest, anything specific to cellular 
agriculture, but instead represents a strong UK body of 
work on the analysis of emerging technologies in general. This 
academic work has fed into the emerging policy discussion, 
about how cellular agriculture should be regulated and what 
role it might have in society if realised as a commercial reality. 
However, beyond the organisation Cultivate, there are few 
formal links between the social scientists and those conducting 
laboratory work.
We detailed the two examples of UK cellular agriculture 
laboratory work beyond CM; the leather work and Manchester 
University and the MP² Project. As we noted, the MP² 
Project—focused upon a fermentation-based palm oil system—
demonstrates that cellular agriculture approaches need not be 
limited to animal-derived products and suggests that the com-
mon-use definition of cellular agriculture could be expanded to 
include non-animal agricultural products, including oils.
Overall, our review has shown that the UK is not the leading 
country in the world in cellular agriculture, but it does have 
an active and diverse community. Given the knowledge base 
within relevant fields in the UK, there is also significant 
potential for this body of work to increase in the coming years. 
We have provided this review to inform interested parties about 
who is active and what they are doing in the UK as 2020 
begins, both for the benefit of audiences keen to engage in 2020, 
and to record this moment of emergence for the historical 
record. The future of cellular agriculture is indeterminate, but it 
seems likely the UK will continue to be involved in the coming 
years.
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The authors state that the aim of cellular agriculture is “to reduce (or entirely replace) animal 
agriculture”, however I don’t agree in totality with this statement as it is highly unlikely that 
complete replacement of animal agriculture will be achieved with the existing capacity. A partial 
replacement is more realistic.  
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An interesting proposal was made by the authors to extend the current definition of cellular 
agriculture to include cell-based agricultural goods that are not sourced from animals with a 
particular reference to fermentation-based palm oil from yeast. This is an interesting concept that 
falls within a different product category with potential benefits, however I would have liked to 
read more about these benefits, as there is only a brief statement saying that “this work ties to 
typical environmental and animal welfare concerns”, but doesn’t explicitly describe those benefits, 
particularly from the animal welfare point of view.  
 
The manuscript is very well written and structured in a logical manner, being very easy to follow 
from one section to another. The conclusions are meaningful and summarize nicely the findings of 
this investigation. There is a lack of peer-reviewed published manuscripts in this domain which 
was acknowledged by the authors. Additionally, the majority of active players in this domain 
worldwide belong to the private sector and don’t publicize their proprietary technology or the 
stage of development that they are at. As such, it is difficult to assess the timeline to a marketable 
cellular agriculture product, it being cultivated meat or other (e.g. leather, milk).
 
Is the topic of the review discussed comprehensively in the context of the current 
literature?
Yes
Are all factual statements correct and adequately supported by citations?
Partly
Is the review written in accessible language?
Yes
Are the conclusions drawn appropriate in the context of the current research literature?
Yes
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Bioprocessing of stem cells, cultivated meat, bioreactors, scale up, cell therapy 
manufacturing.
I confirm that I have read this submission and believe that I have an appropriate level of 
expertise to confirm that it is of an acceptable scientific standard.
Author Response 01 May 2020
Neil Stephens, Brunel University London, Uxbridge, UK 
We thank the reviewer for these useful and positive comments. We have made three 
specific edits to the paper in response to the comments. 
 
First, we have clarified our use of “tissue engineering based” cellular agriculture to show 
that we include non-structured cultured meat within this. We did not want to use a different 
term as that phrase has already been used in published work elsewhere. 
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Second, we made a slight edit to acknowledge that partiality of animal agriculture 
replacement by saying one aim of cellular agriculture is “perhaps entirely replacing” animal 
agriculture. 
 
Thirdly, we have added a short line on the claimed benefits of a cellular agriculture 
approach to palm oil production, noting it is: “specifically around deforestation and its 
impact upon greenhouse gases and biodiversity”.  
Competing Interests: No competing interests were disclosed.
Reviewer Report 11 February 2020
https://doi.org/10.21956/wellcomeopenres.17190.r37682
© 2020 Post M et al. This is an open access peer review report distributed under the terms of the Creative 
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited.
Joshua Flack  
Mosa Meat, B.V., Maastricht, The Netherlands 
Mark J. Post   
Department of Physiology, Maastricht University, Maastricht, The Netherlands 
This review provides a timely record of the current state of the Cellular Agriculture field in the 
United Kingdom. As the authors surmise, the UK is a leading nation in terms of scientific research, 
but arguably has been somewhat ‘behind the curve’ in terms of Cellular Agriculture. As the authors 
detail, this is now changing, although the developments in the UK are more below the radar than 
the activities in the US, Israel and several European nations, such as the Netherlands. 
  
The overview constitutes a useful resource for those looking for an entry point into understanding 
the UK-based Cellular Agriculture landscape. It provides a good cross-sectional view of all activities 
in this space in the UK, with some comparison to other nations. 
  
The authors struggle with the inclusivity of the term cellular agriculture, more specifically whether 
to include all biotechnology using recombinant technology in micro-organisms, i.e. fermentation. 
The existing industry in this space, that historically predates cellular agricultural activities by some 
decades and which focusses on many applications in addition to agricultural products and food, 
will likely not recognize itself in this qualification. Fortunately, to date there is no practical 
confusion over the term cellular agriculture, but with advancing technologies and the emergence 
of cross-over technologies as well as applications, the term will become less defining. 
  
As in most other countries, the rapid emergence of cellular agriculture in the UK, depends on 
privately funded initiatives in the absence of public funding. As reported, there were some 
government initiatives to get a clear understanding of the field during the Cameron 
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administration, but this apparently has faded in the wake of government changes and obvious 
focus on other subjects. In various countries on the continent and indeed in Brussels itself, 
consultations have started and political views are being formed, hopefully followed by funding or 
permissive legislative activities. In this respect it will be interesting and challenging how the recent 
political developments in the UK will affect the current or future collaborative projects in the 
Cellular Agriculture space with European partners. This will especially be important for future 
regulation. Europe has been leading the way in defining how cellular agriculture products, 
specifically cultured meat, will be regulated. It is unknown how the UK will manage regulation of 
novel food products in the near future. The authors might want to speculate or have insight into 
what is a likely regulatory scenario. 
  
Nevertheless, it is encouraging to learn that there are many academic groups involved in cellular 
agriculture, one way or the other. This is attested by the relatively large number of scientific 
publications coming out of UK academic groups, a majority of them on social science aspects. On 
the laboratory science level, it should be mentioned that the Dutch start-up Meatable was co-
founded by a UK-based academic, Mark Kotter, and is making use of stem cell technologies 
developed in his laboratory in Cambridge. 
  
The discussion related to the ‘full-stack’ nature of Higher Steaks as a Cellular Agriculture company 
is an interesting point, and one that might warrant further discussion should the authors wish. Do 
the authors foresee that such vertically integrated companies will ever come to dominate the UK-
based Cellular Agriculture scene? Vertical integration seems to be a business model from the past 
and the current attempts to vertical integration by startup companies should be viewed as the 
result of a lack of suppliers active in this space. It would therefore be good to define what the 
strength of UK-based companies or academic groups is and how they would fit in an eventual 
cellular agricultural industry.  
  
In this rapidly changing field, any publication is inevitably out of date at the time of publication. 
For example, Memphis Meats recently announced a large Series B funding round ($161M).  
  
The authors are in an excellent position to suggest future paths that Cellular Agriculture research 
in the UK might take, and what strategies should be employed to maximize the efficacy of the 
current projects and thus improve or accelerate the growth of Cellular Agriculture in the UK and 
the rest of the world.
 
Is the topic of the review discussed comprehensively in the context of the current 
literature?
Yes
Are all factual statements correct and adequately supported by citations?
Yes
Is the review written in accessible language?
Yes
Are the conclusions drawn appropriate in the context of the current research literature?
Yes
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Competing Interests: The reviewers are employees of Mosa Meat, B.V. a Dutch startup that aims 
to commercialise cultured meat
Reviewer Expertise: Tissue engineering; cultured meat; Physiology.
We confirm that we have read this submission and believe that we have an appropriate level 
of expertise to confirm that it is of an acceptable scientific standard.
Author Response 01 May 2020
Neil Stephens, Brunel University London, Uxbridge, UK 
We thank the reviewers for their comments on the paper. We acknowledge that the paper 
was published just prior to Memphis Meat’s $161 Series B, but we have not included this as 
the review is intended to be accurate as of the end of 2019. 
 
We have edited the paper following this review in that we have now included a paragraph 
about Mark Kotter’s work with Meatable, and we thank the reviewers for highlighting this to 
us.  
Competing Interests: No competing interests were disclosed.
Reviewer Report 06 February 2020
https://doi.org/10.21956/wellcomeopenres.17190.r37683
© 2020 Abergel E. This is an open access peer review report distributed under the terms of the Creative 
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited.
Elisabeth Abergel   
Department of Sociology and Institute for Environmental Science, University of Quebec at 
Montreal (UQAM), Montreal, Canada 
The article sets out to provide an inventory of the field of Cellular Agriculture in the UK including 
the private and public researchers and companies, investors as well as a very broad overview of 
the types of products they are developing. There is also a section on social science, which aims to 
situate how academics studied and were instrumental in opening up various aspects of CM in 
several disciplinary contexts such as sociology, bioethics, law, political framing, environmental 
assessments, etc. 
 
There is a very synthetic but well crafted introduction which retells the story of CM and includes 
some notable UK references, notably Winston Churchill's famous quotation as well as the highly 
publicized tasting of the first "lab-grown burger" which took place in London. 
 
The paper highlights current and recent developments in the UK within the Cell Agriculture space 
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in relations to other countries (US, Holland and Israel for instance). The authors also describe 
three studies of the environmental impact assessments of potential Cellular Agriculture systems 
emanating from the UK. Hence, readers get a snapshot of the UK's involvement in and 
contributions to Cellular Agriculture since its beginning until the end of 2019.  
 
The article is very descriptive and offers very little analytical perspective as is expected from the 
authors' stated objectives. In terms of the review methodology and the purpose of the article, the 
contents are coherent and follow a logical order. The authors are extremely knowledgeable in the 
field of Cellular Agriculture in the UK on the scientific and social science side. They have been 
involved in this issue since its beginnings in the UK and internationally. Their involvement in the 
field is acknowledged in the review methodology. 
 
However, one cannot help question the purpose of this paper from an academic and scholarly 
point of view. While it spans, it seems, a great variety of actors and players in Cellular Agriculture, 
it lacks in depth and possibly critical distance as the authors feature prominently in the article. It is 
on some level very self-referential. One also wonders who the intended target audience might be 
as the article provides some technical details of scientific developments but leaves out broader 
information about key findings of studies from its "portfolio" of social science research.  
 
For instance: 
While the paper discusses scientific research and social sciences contribution to the field, 
what are the links between these communities, if any (besides the Cultivate 
organization and the authors)? 
 
○
One would have liked to have known the role of UK scientists, entrepreneurs and/or 
investors who promote Cellular Agriculture at the international level through 
association meetings, start-up events and conferences? The scope of influence of people 
like Illtud Dunsford for example (Cellular Agriculture Ltd) who represents the farmer's 
perspective at CM events organized outside the UK (he is mentioned in the paper as coming 
from a farming background but he is also partnered with M.E. one of the authors). 
 
○
What are the ties between university researchers and private companies in terms of shared 
levels of expertise, within the UK and outside the UK and in terms of funding besides 
funding doctoral students? 
 
○
Does the UK demarcate itself in terms of expertise, technologies, areas of research, 
patented technologies, expected products, infrastructure, etc.? Why is the University of Bath 
such a leader?  
 
○
What might be occurring in terms of government involvement? What regulatory 
developments, if any? 
 
○
How and who funded the social sciences research conducted in the UK? Who funds Cultivate 
(created by both authors as a forum for discussing UK cellular agriculture)? 
 
○
Who are the institutional actors and related industries supporting cellular agriculture in the 
UK? And what roles do they play in the development of the field?
○
The paper reads almost as a promotional piece, it doesn't delve into deeper questions. It is, as 
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stated earlier, an inventory of sorts. One of the interesting points raised in the article is the brief 
discussion about potentially expanding the definition of cellular agriculture to include non-animal 
sourced products. This could have been discussed further as definitions and language are very 
strategic in Cellular Agriculture but also, to not leave readers with the impression that including 
fermentation based palm oil production was placed there because it is an active area of research 
in the UK. It raises questions about how far the definition of Cellular Agriculture can be expanded.
 
Is the topic of the review discussed comprehensively in the context of the current 
literature?
Yes
Are all factual statements correct and adequately supported by citations?
Yes
Is the review written in accessible language?
Yes
Are the conclusions drawn appropriate in the context of the current research literature?
Yes
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Sociology of science and technology, biotechnology and the bioeconomy, 
agricultural technologies, sustainable food systems, food future, gender and food, and food 
ethics.
I confirm that I have read this submission and believe that I have an appropriate level of 
expertise to confirm that it is of an acceptable scientific standard, however I have 
significant reservations, as outlined above.
Author Response 01 May 2020
Neil Stephens, Brunel University London, Uxbridge, UK 
We thank the reviewer for their thoughtful comments, and we have made a number of 
improvements to the paper in response. We respond to each of the major points in turn 
below.
one cannot help question the purpose of this paper from an academic and scholarly 
point of view. While it spans, it seems, a great variety of actors and players in Cellular 
Agriculture, it lacks in depth and possibly critical distance as the authors feature 
prominently in the article. It is on some level very self-referential. One also wonders 
who the intended target audience might be as the article provides some technical 
details of scientific developments but leaves out broader information about key 
findings of studies from its "portfolio" of social science research.
○
This critique mirrors the comments of another of the reviewers, and we have responded by 
extending the opening paragraph to give a clear statement of what the paper aims to 
achieve, and who we think will benefit from it. In terms of purpose, for us, the paper is one 
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stage in a set of activities that we are engaged in that will support a deeper and more 
critically engaged discussion about cellular agriculture in the UK. In this regard this paper is 
very important to us as a baseline for a broader discussion. Finally on this, one reason this 
journal is a good fit for this specific paper is it requirements in terms of purpose: “All new 
findings supported by original source data are welcome, regardless of the perceived 
interest and the extent of novelty”.
While the paper discusses scientific research and social sciences contribution to the 
field, what are the links between these communities, if any (besides the Cultivate 
organization and the authors)?
○
We are not aware of any further links, but we cannot definitively say there are none. We 
have added a line to the paragraph in the conclusion about the social science work on CM 
noting that these links are limited.
One would have liked to have known the role of UK scientists, entrepreneurs and/or 
investors who promote Cellular Agriculture at the international level through 
association meetings, start-up events and conferences? The scope of influence of 
people like Illtud Dunsford for example (Cellular Agriculture Ltd) who represents the 
farmer's perspective at CM events organized outside the UK (he is mentioned in the 
paper as coming from a farming background but he is also partnered with M.E. one 
of the authors).
○
This paper was not intended to detail the activities of UK groups in the international 
context, or judge their influence (although we do note the role of UK investors in non-UK 
companies). So we have not addressed this point as it is beyond the paper’s remit.
What are the ties between university researchers and private companies in terms of 
shared levels of expertise, within the UK and outside the UK and in terms of funding 
besides funding doctoral students?
○
The paper identifies multiple ties between universities and private companies. Cellular 
Agriculture Ltd is developing technology from the University of Bath, CellulaREvolution is 
developing technology from Newcastle University, Higher Steaks is working with the 
University of Edinburgh, and (featured in this revised version) Meatables is commercialising 
technology from Cambridge University.
Does the UK demarcate itself in terms of expertise, technologies, areas of research, 
patented technologies, expected products, infrastructure, etc.? Why is the University 
of Bath such a leader?
○
This is an interesting question but we do not believe that ‘the UK’ is close enough to a 
singular organised group that does actively demark or self-define itself. As the paper shows, 
activity in the UK is characterised by a relatively small number of groups, many of which are 
relatively early in their operations. We have added a new line to the conclusion that 
comments on the University of Bath: “The University of Bath is a leading institution among 
these, in part as it was an early-mover, and due to its existing track-record in bioprocessing, 
but also partly due to chance in that Bath has three separate groups (one of which is based 
in the Department of Psychology, two based in the Department of Chemical Engineering ) 
that have independently chosen to work in this area”.
What might be occurring in terms of government involvement? What regulatory 
developments, if any?
○
The government has said very little formally on this topic. As noted in the new introduction, 
this paper has been produced in part to allow stakeholders such as the government to more 
easily identify activity in the UK in anticipation of possible future policy discussion in the UK.
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How and who funded the social sciences research conducted in the UK?○
Following this comment and that of another reviewer, the section on UK social science has 
been edited substantially to both increase the coverage of the content of the social science 
work, and identify its funding sources where they are known. However, this has been done 
while working to retain the succinct overview quality of the paper.
Who funds Cultivate (created by both authors as a forum for discussing UK cellular 
agriculture)?
○
The paragraph overviewing Cultivate now includes these details: “The organisation operates 
without external funding and functions with low costs. Events are supported by attendee 
entrance fees and founder contributions.”
Who are the institutional actors and related industries supporting cellular agriculture 
in the UK? And what roles do they play in the development of the field?
○
We are a little confused by this comment, as the paper primarily functions to list the key 
institutional actors and the role they play in the development of the field, so we feel this is 
already addressed across the paper. 
 
Thanks again for your comments, we hope you agree this is now an improved manuscript.  
Competing Interests: No competing interests were disclosed.
Reviewer Report 03 February 2020
https://doi.org/10.21956/wellcomeopenres.17190.r37681
© 2020 Rønning S. This is an open access peer review report distributed under the terms of the Creative 
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited.
Sissel Beate Rønning   
Nofima AS, Ås, Norway 
This manuscript gives an overview of the cellular agriculture in UK, and it presents information on 
a relatively unexplored subject where publication of data is still limited. The manuscript 
summarizes nicely the research activity, and the commercial activities in the UK, and I hope the 
authors will extend this work to include rest of Europe in their next review. As the authors are 
among the most active researchers in the UK on the topic, this unfortunately implies they review 
and refer to much of their own work. This is a limitation of the manuscript, and although the 
authors address this in the review methodology the authors must be careful to provide a balanced 
and comprehensive overview of the research field. I think this manuscript is important, well 
performed and I recommend it for indexing if the authors address my comments. 
  
Comments:
Could the authors emphasize even more the objective of this review? Why is it necessary 
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I am surprised there is such limited research (and investments) on fermentation-based cell 
agriculture in UK. According to reports such as the RethinkX report, these types of products 
are more likely to reach the market sooner compared with tissue-based cell agriculture. 
Perhaps the authors could comment on this interesting fact? Also, in this report the authors 
predict a total collapse of food production as we see it today, and how to handle post-
animal production is not something we should ignore in the future. Who will/should 
produce cultured meat (local farmers, agribusiness, bioscientists, pharmaceutical business)? 
What effect will synthetic protein production/cellular agriculture have on the conventional 
agricultural sector? How to prepare for its arrival? And what about other markets, such as 
production of growth factors, fish feed, pet food? According to White Paper from World 
Economic Forum in 2019, “public support for alternative proteins will most likely be 
suppressed if the social costs of their adapter are seen to high”. Perhaps some of these 
questions could be addressed in this manuscript? 
 
○
The text is sometimes incoherent and unfocused. For example, a short historical 
introduction to cell agriculture is given in the beginning of introduction. Then another 
historical section, describing Churchill and the first burger is described in another chapter; 
cell agriculture-related work in UK. In my opinion this could be moved to the introduction, 
keeping the chapters more focused. 
 
○
I missed information on the technology transfer between medical field and the field of cell 
agriculture. i.e. production of vaccines, tissue engineering, production of insulin and so on. 
What is similar, and what differs? 
 
○
The authors point out that “substantial technical hurdles remain”. In order to help the 
reader, could the authors perhaps describe briefly those challenges, not just refer to them?  
 
○
In my opinion the readability of the manuscript will increase with tables and graphics. 
 
○
Obviously, Stephens is an expert in social science, and I think the manuscript will benefit 
from extending the chapter on social science to not just mention all the studies and reports 
of social sciences, but also the results and conclusions of these works.
○
 
Is the topic of the review discussed comprehensively in the context of the current 
literature?
Yes
Are all factual statements correct and adequately supported by citations?
Yes
Is the review written in accessible language?
Yes
Are the conclusions drawn appropriate in the context of the current research literature?
Yes
Competing Interests: No competing interests were disclosed.
 
Page 21 of 23
Wellcome Open Research 2020, 5:12 Last updated: 19 OCT 2020
Reviewer Expertise: Food Sciences, cultured meat, muscle cell biology.
I confirm that I have read this submission and believe that I have an appropriate level of 
expertise to confirm that it is of an acceptable scientific standard, however I have 
significant reservations, as outlined above.
Author Response 01 May 2020
Neil Stephens, Brunel University London, Uxbridge, UK 
Thank you for your review of our paper. We have edited the text to address the issues 
raised. Below we detail our response to the core comments in turn:
Could the authors emphasize even more the objective of this review? Why is it 
necessary with this review and most importantly: who is it for?
○
We have more than doubled the length of the opening paragraph to state explicitly the 
purpose of the review. We also note that we believe it will be useful for diverse actors within 
the UK policy and practice as a building block for subsequent discussion. We plan to use the 
review as a resource in future work we will be conducting in this context ourselves.
I am surprised there is such limited research (and investments) on fermentation-
based cell agriculture in UK. According to reports such as the RethinkX report, these 
types of products are more likely to reach the market sooner compared with tissue-
based cell agriculture. Perhaps the authors could comment on this interesting fact? 
Also, in this report the authors predict a total collapse of food production as we see it 
today, and how to handle post-animal production is not something we should ignore 
in the future. Who will/should produce cultured meat (local farmers, agribusiness, 
bioscientists, pharmaceutical business)? What effect will synthetic protein 
production/cellular agriculture have on the conventional agricultural sector? How to 
prepare for its arrival? And what about other markets, such as production of growth 
factors, fish feed, pet food? According to White Paper from World Economic Forum in 
2019, “public support for alternative proteins will most likely be suppressed if the 
social costs of their adapter are seen to high”. Perhaps some of these questions could 
be addressed in this manuscript?
○
We do not have a robust answer to the question of why there is limited fermentation-based 
cellular agriculture in the UK. The core role of this paper is simply to note that this is the 
case. It is also beyond the remit of this paper to devise an account of what impact cellular 
agriculture may have on food production and other markets going forward. However, as we 
noted above and in the edited introduction, in the UK context we hope this paper will be 
one step in supporting an informed discussion that can start to address these issues.
The text is sometimes incoherent and unfocused. For example, a short historical 
introduction to cell agriculture is given in the beginning of introduction. Then another 
historical section, describing Churchill and the first burger is described in another 
chapter; cell agriculture-related work in UK. In my opinion this could be moved to the 
introduction, keeping the chapters more focused.
○
We have moved this text as suggested, and agree it improves the paper.
I missed information on the technology transfer between medical field and the field 
of cell agriculture. i.e. production of vaccines, tissue engineering, production of 
insulin and so on. What is similar, and what differs?
○
This is an interesting topic, but we feel this is beyond the focus of this particular paper in 
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terms of the objectives it has set out.
The authors point out that “substantial technical hurdles remain”. In order to help the 
reader, could the authors perhaps describe briefly those challenges, not just refer to 
them?
○
We have added a brief description as requested, in which we note: “This includes producing 
culture media at a lower cost;, developing cell lines that have the capacity for indefinite 
propagation and have a high culture-efficiency to maximise product yield;, developing 
reliable automation and bioreactor systems to enable scale-up that is net-zero carbon;, and 
reproducing the taste, texture and nutritional profile of familiar peat products”.
In my opinion the readability of the manuscript will increase with tables and graphics.○
We have decided not to include any additional tables or graphics, as we were unable to 
think of what data would appropriately and succinctly be captured in table form.
Obviously, Stephens is an expert in social science, and I think the manuscript will 
benefit from extending the chapter on social science to not just mention all the 
studies and reports of social sciences, but also the results and conclusions of these 
works.
○
This section has been extended substantially, more than doubling the text to provide 
further information on the context of these social science projects and signposting some 
key findings. It would be possible to expand further on each example, however we believe 
the current form maintains the right balance between detail and succinctness.  
Competing Interests: No competing interests were disclosed.
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